Journal of Viral Hepatitis

Cover image for Vol. 14 Issue 8

August 2007

Volume 14, Issue 8

Pages 523–598

  1. ORIGINAL ARTICLES

    1. Top of page
    2. ORIGINAL ARTICLES
    1. A health economic model to assess the cost-effectiveness of PEG IFN α-2a and ribavirin in patients with mild chronic hepatitis C (pages 523–536)

      S. Gerkens, M. Nechelput, L. Annemans, B. Peraux, M. Mouchart, C. Beguin and Y. Horsmans

      Version of Record online: 11 JAN 2007 | DOI: 10.1111/j.1365-2893.2006.00831.x

      • image
      • image
      • image
    2. Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection (pages 537–548)

      T. N. Q. Pham, P. M. Mulrooney-Cousins, S. E. Mercer, S. A. MacParland, M. Inglot, M. Zalewska, K. Simon and T. I. Michalak

      Version of Record online: 18 JAN 2007 | DOI: 10.1111/j.1365-2893.2006.00834.x

      • image
      • image
      • image
      • image
      • image
    3. Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications (pages 556–563)

      P. Pradat, H. L. Tillmann, S. Sauleda, J.-H. Braconier, G. Saracco, M. Thursz, R. Goldin, R. Winkler, A. Alberti, J.-I. Esteban, S. Hadziyannis, M. Rizzetto, H. Thomas, M. P. Manns, C. Trepo and for the HENCORE group

      Version of Record online: 21 DEC 2006 | DOI: 10.1111/j.1365-2893.2006.00829.x

      • image
      • image
    4. Staphylococcus aureus bacteremia in patients receiving pegylated interferon-alpha and ribavirin for chronic hepatitis C virus infection (pages 564–569)

      D. Webster, R. Ahmed, P. Tandon, L. Chui, R. R. McDonald, A. Obarianyk, N. Antonishyn and K. Doucette

      Version of Record online: 21 DEC 2006 | DOI: 10.1111/j.1365-2893.2006.00828.x

      • image
      • image
    5. The burden of hepatitis C in England (pages 570–576)

      M. J. Sweeting, D. De Angelis, L. J. Brant, H. E. Harris, A. G. Mann and M. E. Ramsay

      Version of Record online: 30 APR 2007 | DOI: 10.1111/j.1365-2893.2007.00851.x

      • image
      • image
      • image
    6. Serum adiponectin in chronic hepatitis C and B (pages 577–583)

      D. Siagris, G. Vafiadis, M. Michalaki, A. Lekkou, I. Starakis, M. Makri, V. Margaritis, M. Christofidou, A. C. Tsamandas and C. Labropoulou-Karatza

      Version of Record online: 30 APR 2007 | DOI: 10.1111/j.1365-2893.2007.00850.x

    7. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales? (pages 584–591)

      A. Judd, M. Hickman, V. D. Hope, A. J. Sutton, G. V. Stimson, M. E. Ramsay, O. N. Gill and J. V. Parry

      Version of Record online: 14 FEB 2007 | DOI: 10.1111/j.1365-2893.2007.00844.x

      • image
      • image
    8. Cellular and humoral immune response to a third generation hepatitis B vaccine (pages 592–598)

      A. Schumann, M. Fiedler, U. Dahmen, H. Grosse-Wilde, M. Roggendorf and M. Lindemann

      Version of Record online: 30 APR 2007 | DOI: 10.1111/j.1365-2893.2007.00848.x

      • image
      • image
      • image
      • image

SEARCH

SEARCH BY CITATION